Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Lipoprotein Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02644239
What this trial is testing

Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy

Who this might be right for
EpilepsyCardiovascular DiseaseNon-alcoholic Fatty Liver Disease+1 more
University of Sao Paulo 60
Early research (Phase 1)Study completedNCT07423598
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels

Who this might be right for
Healthy Participants
AstraZeneca 40
Not applicableWithdrawnNCT01064934
What this trial is testing

Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)

Who this might be right for
Hyperlipoproteinemia(a)Progressive Cardiovascular Disease
Charite University, Berlin, Germany
Post-approval studies (Phase 4)Study completedNCT00006190
What this trial is testing

Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Large-scale testing (Phase 3)Study completedNCT00654446
What this trial is testing

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Who this might be right for
Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca 442
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317
What this trial is testing

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 780
Not applicableStudy completedNCT05911724
What this trial is testing

Association Between Inflammatory Biomarkers in CVD Patients on Empagliflozin.

Who this might be right for
Stable AnginaHeart Failure
Damanhour University 180
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Early research (Phase 1)Looking for participantsNCT07428473
What this trial is testing

STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Elevated LDL-C and High Cholesterol
Monash University 64
Not applicableStudy completedNCT01216956
What this trial is testing

Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia

Who this might be right for
Insulin SensitivityLipoproteins MetabolismNon Esterified Fatty Acid Kinetics+1 more
Centre de Recherche en Nutrition Humaine Rhone-Alpe 24
Large-scale testing (Phase 3)Study completedNCT00713167
What this trial is testing

The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL)

Who this might be right for
Hyperlipidemia
Shahid Beheshti University of Medical Sciences 55
Testing effectiveness (Phase 2)Study completedNCT01380730
What this trial is testing

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

Who this might be right for
Hyperlipidemia
Amgen 631
Not applicableStudy completedNCT02075710
What this trial is testing

Dietary Treatment Study of Fat Synthesis and Risk of Cardiovascular Disease

Who this might be right for
Overweight and Obesity
University of California, San Francisco 33
Post-approval studies (Phase 4)Study completedNCT01454011
What this trial is testing

The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups

Who this might be right for
Secondary Hypogonadism
Gulhane School of Medicine 140
Large-scale testing (Phase 3)Study completedNCT04807400
What this trial is testing

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Who this might be right for
Atherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease Risk EquivelentsElevated Low Density Lipoprotein Cholesterol
Novartis Pharmaceuticals 892
Not applicableStudy completedNCT01200160
What this trial is testing

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Who this might be right for
Cardiovascular Diseases
Abbott 128
Post-approval studies (Phase 4)Study completedNCT00395486
What this trial is testing

ROMEO (Rosuvastatin in Metabolic syndrOme)

Who this might be right for
Metabolic Syndrome X
AstraZeneca 258
Early research (Phase 1)Study completedNCT04774003
What this trial is testing

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C

Who this might be right for
Hyperlipidemia
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT01483950
What this trial is testing

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Who this might be right for
Hypercholesterolaemia
AstraZeneca 800
Large-scale testing (Phase 3)Study completedNCT00050479
What this trial is testing

Laser and Medical Treatment of Diabetic Macular Edema

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 100
Next Page